Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada

BACKGROUND: A cost-minimization analysis (CMA) was performed to evaluate the economic implications of introducing the SQ Tree sublingual immunotherapy (SLIT)-tablets marketed as ITULATEK® (Health Canada regulatory approval in April 2020) for the treatment of pollen-induced (birch, alder and/or hazel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Anne K., Gagnon, Rémi, Hammerby, Eva, Shen, Julia, Gosain, Sheena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264484/
https://www.ncbi.nlm.nih.gov/pubmed/34238358
http://dx.doi.org/10.1186/s13223-021-00565-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264484/
https://www.ncbi.nlm.nih.gov/pubmed/34238358
http://dx.doi.org/10.1186/s13223-021-00565-y

Ejemplares similares